Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018

What we do
About us
News & events
Investors
Careers

Back
Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 
 12:45:00 PM

Keep reading
Immunicum AB (publ) Announces Nomination Committee for AGM 2019Read